Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease.
Lee M, Son MJ, Hong SH, Ryu JS, Min JH, Lee DE, Lee JH, Kim ND, Park SY, Kim D, Joo J, Kwak J, Kim KH, Lee YH, Keum BR, Song HS, Jung Y, Kim KS, Kim GH.
Lee M, et al. Among authors: kim nd.
Clin Transl Med. 2024 Oct;14(10):e1816. doi: 10.1002/ctm2.1816.
Clin Transl Med. 2024.
PMID: 39367660
Free PMC article.
No abstract available.